Sun Pharmaceutical Industries Ltd.

BSE: SUNPHARMA524715ISIN INE044A01036

Healthcare
Pharmaceuticals
BSE SENSEX

Share price

₹1,776.00+4.05 (+0.23%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,047.55
52W low: ₹1,583.60
Off 52W high: -13.26%
1M return: -0.34%
3M return: -8.88%
6M return: -4.02%
1Y return: +4.92%
20D avg volume: 1,09,290
50 DMA: ₹1,826.17
200 DMA: ₹1,809.17

Key ratios Consolidated

Market cap: ₹4,26,112 Cr
Current price: ₹1,776.00
52W high / low: ₹2,047.55 / ₹1,583.60
Face value: ₹1.00
P/E: 38.78
P/B: 4.77
EPS (TTM): ₹45.79
Book value / share: ₹372.11
ROE: —
ROCE: 17.90%
Operating margin: —
Net margin: —
Debt / equity: 0.05
Net debt: ₹-5,689 Cr
Interest cover: 45.61
Dividend yield: 0.90%
Dividend / share (TTM): ₹16.00
Payout: 34.94%
Cash conversion cycle: 122.8 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	16,199	15,300	14,612	15,521	14,478	13,851	12,959	13,675	13,291	12,653	11,983	12,381
	517.32	723.62	458.50	578.84	469.92	464.46	612.87	465.62	354.00	532.55	605.94	250.20
	16,716	16,024	15,070	16,099	14,948	14,316	13,572	14,141	13,645	13,185	12,589	12,631
	12,288	11,721	11,519	11,383	10,781	10,325	9,956	10,349	10,048	9,762	9,672	9,561
	2,319	2,026	2,182	1,813	1,622	1,772	1,845	1,408	1,639	1,557	1,677	1,710
	1,143	1,020	753.34	922.42	1,088	1,048	1,037	1,239	875.10	997.43	982.88	796.49
	3,274	3,227	2,960	2,892	2,765	2,802	2,489	2,552	2,478	2,455	2,299	2,363
	74.67	99.67	85.89	78.36	99.86	74.80	49.14	51.51	69.17	61.54	73.57	34.73
	758.34	738.72	775.47	732.33	729.50	700.55	663.79	630.56	625.91	655.13	650.36	622.14
	5,084	4,692	4,896	4,735	4,204	3,933	4,117	4,190	4,309	3,865	4,212	3,928
	4,428	4,303	3,551	4,717	4,168	3,991	3,616	3,793	3,598	3,424	2,917	3,070
	-1,269	-204.09	0.00	-489.48	0.00	-818.00	-361.68	-316.17	0.00	0.00	-101.64	-69.81
	3,159	4,099	3,551	4,227	4,168	3,173	3,254	3,476	3,598	3,424	2,816	3,000
	1,158	1,188	827.62	826.07	1,031	870.15	1,094	558.86	567.21	552.25	148.93	432.32
	1,995	2,901	2,710	3,381	3,125	2,293	2,154	2,913	3,037	2,861	2,659	2,561
	8.30	12.10	11.30	14.00	13.00	9.50	9.00	12.10	12.70	11.80	11.10	10.50
Key metrics
	3,992	4,937	4,413	5,038	4,997	3,948	3,967	4,158	4,293	4,140	3,539	3,657
	24.60%	32.30%	30.20%	32.50%	34.50%	28.50%	30.60%	30.40%	32.30%	32.70%	29.50%	29.50%
	12.30%	19.00%	18.50%	21.80%	21.60%	16.60%	16.60%	21.30%	22.90%	22.60%	22.20%	20.70%
	3.50%	—	4.20%	—	5.30%	—	4.50%	—	—	—	—	—
	11.90%	10.50%	12.80%	13.50%	8.90%	9.50%	8.10%	10.50%	—	—	—	—
	-36.20%	26.50%	25.80%	16.10%	2.90%	-19.80%	-19.00%	13.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	61,631	58,462	52,578	48,497	43,886	38,654	33,498	32,838	29,066	26,489
	2,278	1,972	1,965	1,354	634.52	921.51	835.52	635.98	1,025	838.76
	63,909	60,434	54,543	49,851	44,520	39,576	34,334	33,473	30,091	27,328
	46,910	44,007	40,114	38,269	34,940	30,528	27,228	28,203	25,067	22,899
	8,341	7,389	6,449	6,904	7,778	7,049	6,153	5,515	5,783	4,463
	3,839	3,812	4,148	3,466	3,572	3,410	3,175	3,414	2,519	2,731
	12,354	11,419	9,973	9,429	8,296	7,301	6,862	6,362	5,967	5,367
	338.59	338.91	231.36	238.47	172.00	127.35	141.43	302.73	555.25	517.57
	3,005	2,938	2,575	2,557	2,529	2,144	2,080	2,053	1,753	—
	19,407	17,768	16,586	15,418	13,155	10,758	9,478	10,271	8,922	8,090
	16,999	16,426	14,430	11,582	9,580	9,048	7,106	5,270	5,025	4,429
	-1,962	-1,307	-677.85	-494.32	-171.45	-4,567	-4,306	-260.64	-1,214	-950.50
	15,037	15,119	13,752	11,088	9,408	4,481	2,799	5,010	3,810	3,479
	3,999	3,554	2,772	1,439	847.59	1,076	514.69	822.80	600.88	845.19
	10,987	11,509	10,965	9,610	8,513	3,389	2,272	4,172	3,208	2,608
	45.70	47.80	45.60	39.90	35.30	13.60	12.10	15.69	11.11	—
Key metrics
	18,380	18,396	16,559	13,883	12,110	6,752	5,021	7,365	6,119	3,997
	29.82%	31.50%	31.50%	28.60%	27.60%	17.50%	15.00%	22.40%	21.10%	15.10%
	17.83%	19.70%	20.90%	19.80%	19.40%	8.80%	6.80%	12.70%	11.00%	9.80%
	—	17.90%	18.90%	—	—	—	—	—	—	—
	12.13%	11.20%	8.40%	10.50%	13.50%	15.40%	2.00%	13.00%	9.70%	—
	4.79%	5.00%	14.10%	12.90%	151.20%	49.20%	-45.50%	30.10%	23.00%	—
	—	8,810	11,944	—	—	—	—	—	—	—
	—	1.08	1.28	—	—	—	—	—	—	—
	—	0.05	0.03	—	—	—	—	—	—	—
	—	-5,689	-8,399	—	—	—	—	—	—	—
	—	122.8	118.8	—	—	—	—	—	—	—
Balance sheet
	—	1,08,785	92,101	—	—	—	—	—	—	—
	—	63,860	52,594	—	—	—	—	—	—	—
	—	9,771	10,269	—	—	—	—	—	—	—
	—	15,510	13,046	—	—	—	—	—	—	—
	—	11,493	10,243	—	—	—	—	—	—	—
	—	2,865	2,528	—	—	—	—	—	—	—
	—	11,114	10,036	—	—	—	—	—	—	—
	—	7,334	6,184	—	—	—	—	—	—	—
	—	22,622	18,194	—	—	—	—	—	—	—
	—	4,082	1,870	—	—	—	—	—	—	—
	—	4,050	1,867	—	—	—	—	—	—	—
	—	31.26	2.52	—	—	—	—	—	—	—
	—	83,880	72,486	—	—	—	—	—	—	—
Cash flow
	—	12,419	14,072	—	—	—	—	—	—	—
	—	-11,344	-5,306	—	—	—	—	—	—	—
	—	-2,513	-7,906	—	—	—	—	—	—	—
	—	3,609	2,129	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	6,142	5,741	4,924	5,688	4,548	5,602	7,186	6,192	5,128	4,498	5,639	5,074
	81.01	140.17	62.93	179.90	72.79	103.69	132.00	68.39	86.30	82.74	118.88	76.80
	6,223	5,881	4,987	5,868	4,621	5,706	7,318	6,260	5,214	4,581	5,758	5,151
	5,020	4,363	4,138	4,512	3,949	4,233	4,706	4,995	4,318	4,323	4,356	4,329
	1,660	1,240	1,229	1,160	996.19	1,067	1,330	1,163	1,225	973.23	1,056	1,122
	347.75	275.04	311.91	413.27	338.09	328.25	325.70	367.48	360.09	306.26	289.50	227.20
	852.00	830.93	703.99	739.62	728.77	715.00	648.91	651.68	662.19	645.48	575.97	590.13
	276.96	278.48	216.92	244.17	248.33	223.29	217.42	215.96	243.75	216.08	217.59	214.92
	315.79	307.92	325.97	338.53	336.30	299.03	291.96	290.97	285.53	369.81	393.04	399.60
	1,911	1,450	1,696	1,685	1,286	1,504	1,894	2,101	1,813	1,836	1,785	1,798
	1,203	1,518	849.01	1,356	671.75	1,473	2,612	1,265	895.64	257.92	1,402	821.28
	0.00	-31.53	0.00	-258.70	0.00	-287.64	0.00	—	—	—	—	-69.81
	1,203	1,486	849.01	1,097	671.75	1,185	2,612	1,265	895.64	257.92	1,402	751.47
	331.70	371.31	240.31	391.66	107.53	431.35	611.62	83.88	32.35	20.10	534.18	30.16
	871.29	1,115	608.70	705.44	564.22	753.53	2,000	1,181	863.29	237.82	867.60	721.31
	3.60	4.60	2.50	2.90	2.40	3.10	8.30	4.90	3.60	1.00	3.60	3.00
Key metrics
	1,796	2,073	1,392	1,680	1,256	1,707	3,121	1,772	1,425	843.81	2,012	1,366
	29.20%	36.10%	28.30%	29.50%	27.60%	30.50%	43.40%	28.60%	27.80%	18.80%	35.70%	26.90%
	14.20%	19.40%	12.40%	12.40%	12.40%	13.50%	27.80%	19.10%	16.80%	5.30%	15.40%	14.20%
	3.70%	—	2.90%	—	3.60%	—	11.30%	—	—	—	—	—
	35.00%	2.50%	-31.50%	-8.10%	-11.30%	24.50%	27.40%	22.00%	—	—	—	—
	54.40%	48.00%	-69.60%	-40.30%	-34.60%	216.80%	130.60%	63.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	22,495	20,755	23,003	20,275	20,812	15,586	12,803	12,532	10,303	7,948
	464.01	419.33	369.43	465.76	279.03	957.92	150.22	1,511	1,271	1,128
	22,959	21,174	23,373	20,741	21,091	16,544	12,953	14,043	11,575	9,076
	18,033	16,834	18,342	17,072	16,412	14,417	10,711	10,790	9,641	8,645
	5,289	4,383	4,691	4,429	5,166	4,585	3,809	3,202	2,728	2,168
	1,348	1,392	1,360	994.41	1,126	1,249	1,200	1,227	1,197	1,166
	3,127	2,911	2,608	2,374	2,157	2,001	1,798	1,703	1,571	1,618
	1,017	947.84	893.21	784.08	472.18	388.10	256.98	408.01	540.92	388.31
	1,288	1,312	1,238	1,601	1,601	1,350	586.81	561.56	552.95	432.23
	6,742	6,194	7,621	6,797	6,178	5,266	3,260	3,514	3,302	2,714
	4,926	4,340	5,031	3,669	4,679	2,127	2,242	3,253	1,934	430.52
	-290.23	-546.34	0.00	-219.02	-2,938	-1,821	-89.56	—	-1,214	-950.50
	4,636	3,794	5,031	3,450	1,741	306.86	2,153	3,253	719.45	-519.98
	1,335	1,171	747.95	591.47	50.33	406.85	13.17	41.86	97.15	25.39
	3,301	2,623	4,283	2,858	1,691	-99.99	2,140	3,211	816.60	-494.59
	13.60	10.90	17.80	11.90	7.00	-0.40	8.92	13.38	3.40	—
Key metrics
	6,940	6,054	7,162	5,834	3,814	2,045	2,997	4,223	1,813	300.56
	30.85%	29.20%	31.10%	28.80%	18.30%	13.10%	23.40%	33.70%	17.60%	3.80%
	14.67%	12.60%	18.60%	14.10%	8.10%	-0.60%	16.70%	25.60%	7.90%	-6.20%
	—	13.00%	23.60%	—	—	—	—	—	—	—
	-4.39%	-9.80%	13.50%	-2.60%	33.50%	21.70%	2.20%	21.60%	29.60%	—
	-26.64%	-38.70%	49.80%	69.10%	1,790.90%	-104.70%	-33.40%	293.20%	265.10%	—
	—	4,958	3,488	—	—	—	—	—	—	—
	—	2.48	0.98	—	—	—	—	—	—	—
	—	0.60	0.45	—	—	—	—	—	—	—
	—	13,002	10,462	—	—	—	—	—	—	—
	—	192.4	191.3	—	—	—	—	—	—	—
Balance sheet
	—	43,060	43,273	—	—	—	—	—	—	—
	—	16,679	18,722	—	—	—	—	—	—	—
	—	417.84	492.02	—	—	—	—	—	—	—
	—	10,166	11,701	—	—	—	—	—	—	—
	—	4,302	3,787	—	—	—	—	—	—	—
	—	1,447	1,044	—	—	—	—	—	—	—
	—	5,145	4,345	—	—	—	—	—	—	—
	—	3,533	3,434	—	—	—	—	—	—	—
	—	6,503	18,149	—	—	—	—	—	—	—
	—	13,420	10,954	—	—	—	—	—	—	—
	—	0.00	10,954	—	—	—	—	—	—	—
	—	13,420	0.00	—	—	—	—	—	—	—
	—	22,371	24,340	—	—	—	—	—	—	—
Cash flow
	—	6,501	4,199	—	—	—	—	—	—	—
	—	-1,381	-209.56	—	—	—	—	—	—	—
	—	-5,230	-3,831	—	—	—	—	—	—	—
	—	1,543	710.51	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: -0.09%
Sales CAGR 5Y: +10.14%
Profit CAGR 3Y: +15.77%
Profit CAGR 5Y: +4.16%
Sales YoY (TTM): -4.39%
Profit YoY (TTM): -26.64%

Consolidated

Sales CAGR 3Y: +10.03%
Sales CAGR 5Y: +11.78%
Profit CAGR 3Y: +10.57%
Profit CAGR 5Y: +38.33%
Sales YoY (TTM): +12.13%
Profit YoY (TTM): +4.79%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 52.66%

Quarter	September 2026	June 2026
Promoter %	52.66%	54.46%

Holder	Type	Holding	Previous	Change
Shanghvi Finance Private Limited	Promoter Group	40.30%	40.30%	0.00%
Dilip.S.Shanghvi	Promoter	9.60%	9.60%	0.00%
Life Insurance Corporation Of India	Public	5.32%	5.53%	-0.21%
Icici Prudential Value Fund	Public	3.21%	3.72%	-0.51%
Sbi Nifty 50 Etf	Public	2.82%	2.36%	+0.46%
Nps Trust- A/C Hdfc Pension Fund Management Limited Scheme E - Tier I	Public	1.96%	1.88%	+0.08%
Aditya Medisales Limited	Promoter Group	1.67%	1.67%	0.00%
Nippon Life India Trustee Ltd-A/C Nippon India Etf Nifty 50 Bees	Public	1.32%	—	—
Raksha Sudhir Valia	Public	1.20%	1.20%	0.00%
Hdfc Trustee Company Ltd. A/C Hdfc Balanced Advantage Fund	Public	1.14%	—	—
Lakshdeep Investments & Finance (P) Ltd.	Public	1.02%	1.02%	0.00%
Government Pension Fund Global	Public	1.01%	1.03%	-0.02%
Unimed Investments Limited	Promoter Group	0.43%	0.43%	0.00%
Vibha Dilip Shanghvi	Promoter Group	0.37%	0.37%	0.00%
Aalok Dilip Shanghvi	Promoter Group	0.12%	0.12%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%

Filings & corporate actions

Recent announcements

Clarification regarding news report relating to the Company''s Assam facility2 Nov 2026 · Others
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting ....2 Nov 2026 · Company Update / Clarification
Completion and results of postal ballot dated 01 October 202631 Oct 2026 · Company Update / General
Newspaper publication for unaudited financial results for the quarter and half year ended 30 September 202631 Oct 2026 · Company Update / Newspaper Publication
Q2FY27- Investor Call Audio Recording30 Oct 2026 · Company Update / General
Board Meeting Outcome - Conclusion30 Oct 2026 · Company Update / General
Unaudited Financial Results for the quarter and half year ended 30 September 202630 Oct 2026 · Result / Financial Results
ILUMYA (tildrakizumab-asmm) approved in the U.S. for the treatment of adults with active Psoriatic Arthritis30 Oct 2026 · Company Update / Press Release / Media Release
Allotment of Non-convertible securities (NCDs) on Private Placement basis26 Oct 2026 · Company Update / Allotment of Equity Shares
Press Release23 Oct 2026 · Company Update / Press Release / Media Release
Press Release20 Oct 2026 · Company Update / Press Release / Media Release
Earnings call for the financial results of the second quarter on 30 October 202615 Oct 2026 · Company Update / Analyst / Investor Meet
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the Unaudited ....14 Oct 2026 · Board Meeting / Board Meeting
Submission of Confirmation Certificate14 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Update on Credit Ratings13 Oct 2026 · Company Update / Credit Rating
Outcome of the Board Meeting held on 12 October 202612 Oct 2026 · Company Update / Resignation of Director
Outcome of the Board Meeting held on 12 October 202612 Oct 2026 · Board Meeting / Outcome of Board Meeting
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve the issuance ....7 Oct 2026 · Board Meeting / Board Meeting
Press Release6 Oct 2026 · Company Update / Press Release / Media Release
Newspaper publication about Postal Ballot/E-voting October 20262 Oct 2026 · Company Update / Newspaper Publication
Notice of Postal ballot October 20261 Oct 2026 · AGM/EGM / Postal Ballot
Press Release is enclosed1 Oct 2026 · Company Update / Press Release / Media Release
Newspaper publication about the opening of Special Window for transfer of physical shares30 Sep 2026 · Company Update / Newspaper Publication
ESG Overview for FY 2025-2629 Sep 2026 · Company Update / General
Completion and Result of Postal Ballot dated 25 August 202628 Sep 2026 · Company Update / General
Press Release for lerodalcibep licensing agreement28 Sep 2026 · Company Update / Press Release / Media Release
Receipt of approval of the shareholders for reclassification of shareholder category26 Sep 2026 · Company Update / General
Trading Window closure25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Investor Presentation Sept-202622 Sep 2026 · Company Update / Investor Presentation
As attached11 Sep 2026 · Company Update / General
Incorporation of wholly owned subsidiary of the Company in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India9 Sep 2026 · Company Update / General
International Credit Ratings8 Sep 2026 · Company Update / Credit Rating
Intimation of Schedule of Analyst/Institutional Investor Meeting3 Sep 2026 · Company Update / Analyst / Investor Meet
Sun Pharma participates in White House Signing Ceremony highlighting U.S. Medicines Pricing and Access Commitments1 Sep 2026 · Company Update / Press Release / Media Release
Newspaper Advertisements about Postal Ballot/E-voting26 Aug 2026 · Company Update / Newspaper Publication
Notice of Postal Ballot/E-voting25 Aug 2026 · AGM/EGM / Postal Ballot
Intimation of Schedule of Analyst/Institutional Investor Meeting25 Aug 2026 · Company Update / Analyst / Investor Meet
Update on Lipitor Antitrust Litigation17 Aug 2026 · Company Update / General
Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group6 Aug 2026 · Company Update / General
Q1FY27 Earnings Call Transcript6 Aug 2026 · Company Update / Earnings Call Transcript

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 5.0000	7 Jul 2026	7 Jul 2026	—
Interim Dividend - Rs. - 11.0000	5 Feb 2026	5 Feb 2026	—
Final Dividend - Rs. - 5.5000	7 Jul 2025	7 Jul 2025	—
Interim Dividend - Rs. - 10.5000	6 Feb 2025	6 Feb 2025	—
Final Dividend - Rs. - 5.0000	12 Jul 2024	12 Jul 2024	—

Board meetings

30 Oct 2026 Board Meeting - Financial Results
31 Jul 2026 Board Meeting - Financial Results